Membrane Oxygenators Market Size by Type, Age Group, End-Use, Region – Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2034
Overview
The Membrane Oxygenators Market size was valued at USD 134.97 Million in 2025 and the total Membrane Oxygenators revenue is expected to grow at a CAGR of 1.8% from 2026 to 2034, reaching nearly USD 158.48 Million.
Membrane Oxygenators Market Overview
A membrane oxygenator is a device used to add oxygen and remove carbon dioxide from the blood. A membrane oxygenator consists of gas-permeable membrane oxygenation (ECMO) to separate the blood, gas flow in the CPB circuit. Membrane oxygenators act as artificial lungs to the human body.
Membrane Oxygenators Market Size, Growth & Share Analysis
To know about the Research Methodology :- Request Free Sample Report
Global Membrane Oxygenators Market Dynamics:
The Membrane oxygenators market is greatly driven by the prevalence of chronic diseases like respiratory diseases, and cardiovascular diseases (CVD). As per the research, around 655,000 Americans die from heart disease each year with a ratio of 1:4. And around 805,000 Americans suffer from heart attacks each year. This factor is likely to boost the demand for membrane oxygenators during the forecast period.
The growth of membrane oxygenators was amplified in the COVID-19 pandemic due to the wider application base of membrane oxygenators in the first two waves of the SAR-Cov-2 around the globe. As of 31 July 2021, around 197,385,970 no. of COVID-19 cases were reported worldwide, and the death rate reported was 4,214,947 and growing and 4 billion people have been vaccinated around the globe. This factor is likely to boost the market growth of membrane oxygenators in hospitals and healthcare facilities.
As per World Health Organization (WHO), around 17.4 million people are departed due to cardiovascular diseases nationwide and this is 31% of the total death rate. The diseases occurrence is duelled by the unhealthy lifestyle patterns, consumption of tobacco, smoking, physical inactivity. This factor acts as a major contributing factor to the growth of the market of membrane oxygenators during the forecast period.
Moreover, membrane oxygenators act as a life-supporting device in chronic diseases and support long-term treatment. Besides, improvements in mass transfer efficiency and membrane technology are fueling the growth of the market. Further, amplified technology and government initiatives are instigating the demand for membrane oxygenators.
Global Membrane Oxygenators Market Segment Analysis:
The Hollow Fiber Membrane Oxygenators segment is anticipated to adhere to the growth of the Type segment of the Membrane Oxygenators Market.
Hollow Fiber Membrane Oxygenators is dominating the type segment of membrane oxygenator and accounted for the largest market share with 62.4% in 2025. The main function of Hollow Fiber Membrane Oxygenators is to separate the patient’s blood and circuit gas during the workflow in oxygenators. Oxygen and carbon dioxide diffuse down their respective concentration ascents through the micropores with minimal direct contact between the blood and gas. These fibers are small as they are covers by protein, mainly plasma protein that is responsible to block the holes forming the semipermeable and result in the exchange of gases.
The flat sheet membrane oxygenator segment is growing at a significant pace in the market and is creating larger opportunities for the market players to invest in the membrane oxygenators market.
The adult age group segment is supplementing the growth of the Global Membrane Oxygenators Market.
Asthma is more common in the adult age group and is dominating the age group segment of membrane oxygenators in the market. Asthma is more common in adult women as compared to adult men. About 20 million US adults (above 18) have asthma and currently, 5.1 million children under the age of 18 are suffering from asthma. Asthma is a leading chronic disease in respiratory illness hence, membrane oxygenators are widely used in asthma treatment.
In 2025, as per the survey by Asthma and Allergy Foundation of America (AAFA), 44.3% of children’s age below 18 had reported asthma with one or more asthma attacks in one year, and around 47.2% of children below the age of 5 with asthma had one episode. Hence, the occurrence of respiratory illness in adults is likely to boost the market for membrane filtration in the future. Moreover, as per the Centers for Disease Control and Prevention (CDC), the episode of asthma has declined in children from 2020 to 2025. Further, the death rate due to asthma in 2025 was 3524 and due to this factor membrane oxygenators are likely to gain more attention in the market.
The Respiratory segment is Trending in the End-User Segment of Global Membrane Oxygenators Market.
The respiratory segment is likely to dominate the end-user segment of membrane oxygenators in the market. The revenue generated by the respiratory segment in 2025 was valued at 54.8% and is likely to grow at a high pace due to the high incidence of respiratory diseases due to the high consumption of tobacco, drinking, and smoking habits. The growth of the respiratory segment is attributed to the use of membrane oxygenators by patients suffering from pulmonary hypertension, respiratory distress syndrome, respiratory failures, severe pneumonia. The main aim of membrane oxygenators is to act as artificial lungs for the human body which plays a vital role in pulmonary functions. Moreover, respiratory illnesses like asthma are hitting the market due to rising pollutions all over the world. For example. Approximately 25 million Americans have asthma. The ratio is 1:13 Americans, plus 8% of adults and 7% of children. This factor is likely to accelerate the adoption of membrane oxygenators by the healthcare facilities in the market.
Global Membrane Oxygenators Market Regional Insights:
The membrane Oxygenators market is regionally segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
North America is leading in the Membrane Oxygenators market due to the presence of renowned market players in North America like Terumo medical corporation and Getinge AB. North America accounts for 44.2% of revenue share in the year 2025. The growth of the region is promoted by the presence of various hospital-based on primary treatment, secondary treatment, and third-level treatment with well-developed infrastructure and healthcare system. This factor is anticipated to support the growth during the forecast period.
In addition, the government fundings, healthcare policies, boosting awareness among the consumers regarding the applications of membrane oxygenators and the benefits. Further, the adoption by the hospitals is likely to boost the market growth in the region. The huge updates and the technological changes in the membrane oxygenator by the market players are likely to fuel the market growth in the forecast period.
The Asia Pacific is estimated to grow at a rapid pace with a CAGR of 3.15 during the forecast period. The growth of the region is attributed to the occurrence of chronic diseases like cardiopulmonary diseases due to consumption of unhealthy food and lifestyle patterns, consumption of tobacco which is cancerous to health. Besides, the adoption of membrane oxygenators in cardiothoracic surgeries by hospitals is further creating demand for membrane oxygenators in the market. This factor is estimated to boost the market growth during the forecast period.
The objective of the report is to present a comprehensive analysis of the Global Membrane Oxygenators Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the Global Membrane Oxygenators Market dynamics, structure by analyzing the market segments and project the Global Membrane Oxygenators Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Membrane Oxygenators Market make the report investor’s guide.
Membrane Oxygenators Market Recent Development:
| Date | Company | Development | Impact |
|---|---|---|---|
| 24 March 2026 | Getinge AB | Getinge received CE mark approval for its next-generation Cardiohelp II ECLS platform, incorporating intelligent monitoring and integrated gas blending. | The approval expands Getinge's footprint in the European critical-care and ECMO transport market by improving clinical workflow efficiency and decision-making precision. |
| 26 November 2025 | Eurosets | Eurosets commercialized its new 8AF Adult Membrane Oxygenator designed to advance performance in cardiopulmonary bypass procedures. | The launch enhances gas-exchange efficiency and blood conservation in high-risk adult cardiac surgeries across European hospital networks. |
| 02 October 2025 | Eurosets | Eurosets introduced the LANDING ADVANCE monitoring platform to complement its membrane oxygenators in VA and VV ECMO procedures. | This system improves real-time physiological tracking, reducing complications during prolonged extracorporeal life support runs. |
| 01 July 2025 | Medtronic plc | Medtronic received CE Mark approval for its VitalFlow ECMO System, an integrated critical-care platform with specialized oxygenation circuits. | The approval enables Medtronic to expand its cardiopulmonary support portfolio across European hospitals, driving competition in life-support medical devices. |
Global Membrane Oxygenators Market Scope: Inquire before buying
| Global Membrane Oxygenators Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 134.97 Mn. |
| Forecast Period 2026 to 2034 CAGR: | 1.8% | Market Size in 2034: | USD 158.48 Mn. |
| Segments Covered: | by Type | Hollow Fiber Membrane Oxygenators Flat Sheet Membrane Oxygenators |
|
| by Age Group | Neonates Pediatrics Adults |
||
| by End-Use | Respiratory Respiratory failure Pulmonary embolism Acute respiratory distress syndrome Pneumonia COVID-19 Cardiac Acute myocardial infarction Myocarditis Post-transplant complications Decompensated cardiomyopathy Cardiogenic shock ECPR |
||
Membrane Oxygenators Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Membrane Oxygenators Market, Key Players are:
1. Medtronic
2. Fresenius SE & Co KGaA
3. Getinge AB
4. Terumo Medical Corporation
5. MicroPort Scientific Corporation
6. Nipro Medical Corporation
7. LivaNova PLC
8. Medtronic
9. EUROSETS
10. Chalice Medical Ltd
11. MAQUET Holding B.V. & Co. KG.
12. XENIOS AG
13. Weigao group
14. MicroPort Scientific Corporation
15. Terumo Medical Corporation.
FAQs:
1. What is the global market share in 2025?
Ans: Approximately, 134.97 million USD.
2. What is the global market growth?
Ans: The global market is anticipated to grow with a CAGR of 1.8% in the forecast period and is likely to reach 158.48 million by the end of 2034.
3. What was the Global Membrane Oxygenators Market size in 2025?
Ans: The Global Membrane Oxygenators Market size was USD 134.97 Million in 2025.
4. Which type segment accounted for the highest market share?
Ans: The hollow fiber membrane oxygenators segment dominated the market and accounted for 62.4% in 2025.
5. What are the key driving factors for the growth of the global market?
Ans: Key factors driving the market growth are the escalating frequency of respiratory and cardiovascular diseases, and the growing no. of extracorporeal membrane oxygenator centers together with the increasing adoption of membrane oxygenators as a bridge to lung transplantation.